People are waiting to hear the fate of Qsymia (or Qnexa?), the obesity combo therapy being developed by Vivus (fixed...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
PHARMACEUTICAL APPROVALS
Pharmaceuticals approvals are the last step in a long process of government testing. This topic tracks the approval of prescription and over-the-counter pharmaceuticals.
Pharmaceutical Approvals is part of Business Exchange, suggested by
Evan Rappaport.
This topic contains
1,740 news
and
318 blog
items.
Read updated news, blogs, and resources about Pharmaceutical Approvals. Find user-submitted articles and reactions on Pharmaceutical Approvals from
like-minded professionals.
Blogs
Recent blog posts on this topic.
People are waiting to hear the fate of Qsymia (or Qnexa?), the obesity combo therapy being developed by Vivus (fixed...
What on earth has been going on at the FDA? The agency has engaged in a large and long-running surveillance of its own...
What on earth has been going on at the FDA? The agency has engaged in a large and long-running surveillance of its own...
There's no escaping politics and health care policy today. No matter what happens to the Affordable Care Act this...
There's no escaping politics and health care policy today. No matter what happens to the Affordable Care Act this...
If you've been following Shire Pharmaceuticals and their Replagal saga, you've had quite a few twists and turns to keep...
If you've been following Shire Pharmaceuticals and their Replagal saga, you've had quite a few twists and turns to keep...
Big news, and unfortunate news for the New Jersey end of the pharma business: Roche is closing down their entire site...
Big news, and unfortunate news for the New Jersey end of the pharma business: Roche is closing down their entire site...
The biggest pharma companies increasingly seem to feel as if they need universities nearby. We've talked about this...
A recent article in Science illustrates a number of points about drug development and scale-up. It's about artemisinin,...
A recent article in Science illustrates a number of points about drug development and scale-up. It's about artemisinin,...
I do hate to bring up rhodanines again, but I'm not the one who keeps making the things. This paper from ACS Medicinal...
I do hate to bring up rhodanines again, but I'm not the one who keeps making the things. This paper from ACS Medicinal...
The NIH's attempt to repurpose shelved development compounds and other older drugs is underway: The National Institutes...
Here's a good example of phenotypic screening coming through with something interesting and worthwhile: they screened...
Here's a good example of phenotypic screening coming through with something interesting and worthwhile: they screened...
For those of you following Arena Pharmaceuticals and their long-running efforts to get lorcaserin approved by the FDA,...
Benlysta got approved for lupus last year, as the first new drug in the field in decades. But as noted at the time, it...
Here's an excellent piece by venture capital guy Bruce Booth, looking back at the heady days of 1991-1994.
Here's an excellent piece by venture capital guy Bruce Booth, looking back at the heady days of 1991-1994.
John LaMattina has a good piece up on the FDA, where they might be trying to have it both ways. About a recent speech...
John LaMattina has a good piece up on the FDA, where they might be trying to have it both ways. About a recent speech...
There have been a number of headlines the last few days about Ranbaxy's Synriam, an antimalarial that's being touted as...
Top Sources: Pharmaceutical Approvals
- SeekingAlpha.com: Home Page
- DODTracker.com New Deals Feed
- stockerblog.blogspot.com
- What's New at CBER
- RSS from PharmiWeb.com
- futurebiopharma.blogspot.com
- In the Pipeline
- FDA Law Blog
- Health News from Medical News Today
- Medical Device Recalls since November 11, 2009
account